Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same here! Why the huge increase?!?!?!?! I LIKE!
GREAT! Thanks SF!
I had a few bids filled also...good grab!
The good old days when we used to watch real sports.....lol!
Turbo your from Chi-town...maybe get triple threat to promote? LOL!
Most know of the progress...just need to have the good word spread to investors.
Again....put a billboard up in the top 10 biggest cities! Cheap and will get attention....just IMO.
New Buyers.......
YES! ELON.........BUY OUT RXMD!!!!!!
Or now being SEC Reporting? That's pretty big......
Hopefully new eyes saw the great news and accomplishment from RXMD yesterday!
I already thru out a thought for probably $2,000/mo RXMD can put up a billboard in the top 10 busiest cities....
This is a huge deal for RXMD! Profits, now SEC reporting..moving in the right direction here!!!
$RXMD - Progressive Care Gains SEC Reporting Status
April 12 2022 - 07:52AM
Progressive Care announced effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange
Miami, FL -- April 12, 2022 -- InvestorsHub NewsWire -- Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company, said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media
NEWS OUT!!!
$RXMD - Progressive Care Gains SEC Reporting Status
April 12 2022 - 07:52AM
Progressive Care announced effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange
Miami, FL -- April 12, 2022 -- InvestorsHub NewsWire -- Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company, said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media
$RXMD - Progressive Care Gains SEC Reporting Status
April 12 2022 - 07:52AM
Progressive Care announced effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange
Miami, FL -- April 12, 2022 -- InvestorsHub NewsWire -- Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company, said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Yes, pay off the debt!
SWEET!!!!!!!!!!!
If I could get some of Jimmy's charts or if someone wants to PM me items, that would be great.
I did some updates. I'll work on it better in the next few days....I have never updated an intro before.
Up 6% good start!
That guys a stud! Get him on the board...probably wouldn't cost him as much! LOL
Agreed! This is a buy and hold stock, not a quick $$$ stock.
With the announcement of 4/11 next week news...5's easy.
Ask $.039 at bell!
Correct MFN. I know a LOT of us own millions here and are waiting patiently for big payday! It's GOING to happen.....
Can't wait Capt! Patience needed here. We will be rich soon enough.....they are going about this the correct way.
I'm still protecting the bid if any weak hands want to sell on this huge filing on Monday?!?!?!
We should see a PR confirming this milestone next week! Great Update!
Perfect! Thanks SF!!!!! Good to hear!
I'm still taking this opportunity to add when I can. When this does take off it's going to go fast. I'll probably sell a small portion on the way up but I don't want to kill the run up. Most is in my IRA so I don't mind holding until this makes me rich. IMO
We should get paid for supporting this stock! Without longs, we would be in the 2's.......Need promotion!
Is it...and probably Brandon's fault.
Maybe a question for the next call is to ask Jay how Clearthink is engaging in active promotion......for our information. That way we could look it up and possibly verify.
$100 trades to bring it down.....almost hilarious....we know what we own!
$RXMD - EASY TEN BAGGER! FINALLY PROFITS! $39 MIL REV Company!!!
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
$RXMD - ONLY $.04!!! PROFITS! Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in Revenue
BY GlobeNewswire
.
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
$RXMD - PROFITS!! $39 MIL REV'S! AUDITED! UNDERVALUED AND NEWS OUT!!! HUGE 2021!!!!!!
$RXMD - FINALLY PROFITS! $39 MIL REV'S! ONLY $.04 CURRENTLY! NEWS OUT!!!!!!
\Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in Revenue
$RXMD- PROFITS! UNDERVALUED! Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in Revenue
BY GlobeNewswire
— 11:16 AM ET 03/29/2022
Positioned for Accelerated Revenue Growth and to Become an SEC Reporting Company in 2022
See on website
Miami, FL, March 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the year ended December 31, 2021.
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
Subsequent Events
• Filed Form 10-12G registration statement with the SEC
Management Commentary
Alan Jay Weisberg, Chairman and Chief Executive Officer of Progressive Care ( RXMD
Loading...
Loading...
), commented, “In 2021 our team overcame many obstacles, macro and company-specific, and we exited the year in a much stronger position regarding our business and capital markets strategy. Our team was able to complete complex implementation of the pharmacy system and get back to growing the pharmacy business, successfully achieve significant revenue from COVID-19 services and position itself to become an SEC reporting company.”
Mr. Weisberg, continued, “We believe that our 4th Quarter 2021 performance and activities have provided us with good momentum, and we expect 1st Quarter 2022 performance to reflect that. Again, I find it important to communicate our company’s mission - the healthier we make our patients, the more successful our business will be, and we will not lose sight of that vision, with the goal of enhancing and creating more value for our shareholders. Progressive Care ( RXMD
Loading...
Loading...
) believes that investments in technology and talent will provide the type of value the company and its shareholders deserve.”
Mr. Weisberg concluded, “We expect that our planned uplist to Nasdaq, once completed, will have an immediate and positive impact on growth of the company, enabling us to increase our operational pace by having access to institutional capital and to pursue the businesses we think will help us roll out our services nationwide at a faster pace. Meanwhile, we will do our part by staying on a steady course of growing our business. We strongly believe that optimism around Progressive Care ( RXMD
Loading...
Loading...
) will soon begin to be reflected in the share price of our stock.”
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
Progressive Care Inc. ( RXMD
Loading...
Loading...
) , through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
https://www.progressivecareus.com/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and
uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc. ( RXMD
Loading...
Loading...
), its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital